Table of Contents:

1 Report Prologue
2 Market Introduction
2.1 Introduction
2.2 Assumptions & Limitations
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Increasing demand for sterile drugs for the treatment of medical conditions such as cancer,
cardiovascular diseases, and others
4.2.2 Growing pharmaceutical and biotechnology sector provides suitable backgrounds for the market growth
4.2.3 Increasing government funding in the medical sector
4.2.4 Rising investments in life sciences
4.2.5 Drivers Impact Analysis
4.3 Restraints
4.3.1 High cost of sterility tests
4.3.2 Prolonged storage of perishable pharmaceutical products and need of trained professionals
4.3.3 Restraints Impact Analysis
4.4 Opportunity
4.4.1 Untapped markets of the Asia Pacific region
4.5 Mega Trends
4.5.1 Increasing adoption of rapid sterility testing
4.6 Macroeconomic Indicator
5 Market Factor Analysis
5.1 Value Chain Analysis
5.1.1 R&D & Designing
5.1.2 Manufacturing
5.1.3 Distribution & Sales
5.1.4 Post-Sales Review
5.2 Porter's Five Forces Model
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Buyers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitutes
5.2.5 Intensity of Rivalry
5.3 Investment Opportunities
5.4 Pricing Analysis
6 Global Sterility Testing Market, by Product Type
6.1 Introduction
6.2 Instruments
6.3 Consumables
6.4 Services
7 Global Sterility Testing Market, by Test Type
7.1 Introduction
7.2 Membrane Filtration Sterility Testing
7.3 Direct Transfer Sterility Testing
7.4 Product Flush Sterility Testing
8 Global Sterility Testing Market, by End User
8.1 Introduction
8.2 Pharmaceutical Companies
8.3 Hospital & Clinics
8.4 Academic & Research Laboratories
9 Global Sterility Testing Market, by Region
9.1 Introduction
9.2 Americas
9.2.1 North America
9.2.1.1 US
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 U.K
9.3.1.4 Italy
9.3.1.5 Spain
9.3.1.6 Rest of Europe
9.3.2 Eastern Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 India
9.4.3 Japan
9.4.4 Australia
9.4.5 Rest of Asia Pacific
9.5 Middle East & Africa
9.6 Middle East
9.6.1 Africa
10 Competitive Landscape
10.1 Competitive Landscape
10.2 Competitive Landscape
10.2.1 Introduction
11 Company Profiles
11.1 Merck KGaA
11.1.1 Company Overview
11.1.2 Products Offering
11.1.3 Key Developments
11.1.4 SWOT Analysis
11.1.5 Key Strategy
11.2 Pacific BioLabs Inc.
11.2.1 Company Overview
11.2.2 Products Offering
11.2.3 Key Developments
11.2.4 SWOT Analysis
11.3 Belimed Deutschland GmbH
11.3.1 Company Overview
11.3.2 Products Offering
11.3.3 Key Developments
11.3.4 SWOT Analysis
11.3.5 Key Strategy
11.4 Boston Scientific Corporation
11.4.1 Company Overview
11.4.2 Products Offering
11.4.3 Key Developments
11.4.4 SWOT Analysis
11.4.5 Key Strategy
11.5 Charles River Laboratories Inc.
11.5.1 Company Overview
11.5.2 Products Offering
11.5.3 Key Developments
11.5.4 SWOT Analysis
11.5.5 Key Strategy
11.6 Sartorius AG
11.6.1 Company Overview
11.6.2 Products Offering
11.6.3 Key Developments
11.6.4 SWOT Analysis
11.6.5 Key Strategy
11.7 BioM?rieux SA
11.7.1 Company Overview
11.7.2 Products Offering
11.7.3 Key Developments
11.7.4 SWOT Analysis
11.7.5 Key Strategy
11.8 Baxter BioPharma Solutions
11.8.1 Company Overview
11.8.2 Products Offering
11.8.3 Key Developments
11.8.4 SWOT Analysis
11.8.5 Key Strategy
11.9 Astell Scientific
11.9.1 Company Overview
11.9.2 Products Offering
11.9.3 SWOT Analysis
11.1 SGS SA
11.10.1 Company Overview
11.10.2 Products Offering
11.10.3 Key Developments
11.10.4 SWOT Analysis
11.10.5 Key Strategy
11.11 Thermo Fisher Scientific Inc.
11.11.1 Company Overview
11.11.2 Products Offering
11.11.3 Key Developments
11.11.4 SWOT Analysis
11.11.5 Key Strategy
11.12 Becton, Dickinson and Company
11.12.1 Company Overview
11.12.2 Products Offering
11.12.3 Key Developments
11.12.4 SWOT Analysis
11.12.5 Key Strategy
11.13 WuXi AppTec
11.13.1 Company Overview
11.13.2 Products Offering
11.13.3 Key Developments
11.13.4 SWOT Analysis
11.14 Bioquell UK Ltd
11.14.1 Company Overview
11.14.2 Products Offering
11.14.3 SWOT Analysis
11.15 Azbil Telstar S.L.
11.15.1 Company Overview
11.15.2 Products Offering
11.15.3 SWOT Analysis
12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEO's View Point
12.2 Key Companies to Watch
13 Appendix
13.1 Discussion Blue Print
13.2 Recent Developments, 2013-2017